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Abstract 
The ether lipid analogs (R)-PAF, (R)-ET-18-OMe and (R)-Lyso-PAF can form bilayers. Using differential scanning calorimetry 
(DSC) and small angle X-ray diffraction, we have investigated bilayers formed entirely of these molecules. Small angle X-ray diffraction 
experiments strongly indicated that these bilayers are interdigitated at98% relative humidity in the gel phase. The slight differences in the 
structures of the ether lipids affect their thermal behavior and packing properties. Of the three, (R)-Lyso-PAF shows the highest phase 
transition temperature, broadest phase transition peak and smallest enthalpy change. These characteristics may be attributed to hydrogen 
bonding of the -OH group at sn-2 position of its glycerol backbone to water or to other (R)-Lyso-PAF molecules. The interdigitated 
structure shows that these bilayers are similar to lipid bilayers and suggests that these molecules could easily insert themselves into 
membranes to reach their respective active sites or to perturb the membranes. The packing and thermal characteristics of (R)-Lyso-PAF 
may help explain its biological inactivity. 
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1. Introduction 
Ether lipids have several important biological activities 
[1-5]. Platelet activating factor (1-O-alkyl-2-acetyl-sn- 
glycero-3-phosphocholine) (PAF) directly or indirectly af- 
fects an astonishing range of physiological processes in a 
wide variety of tissues, and acts as a mediator in several 
disease states [6-8]. PAF is also structurally diverse. The 
sn-1 chains may vary in length, may be saturated or 
unsaturated, and may have either an ether or ester linkage 
[9]. One ether lipid analog investigated in this work, 
( R)- 1 -O-octadecyl -2-O-acety l -sn-g lycero-3-phosphocho-  
line [(R)-PAF] (Fig. 1), acts as a platelet activating factor 
[ 10]. Another, (R)- 1-O-octadecyl-2-O-methyl-sn-glycero- 
3-phosphocholine [(R)-ET- 18-OMe], not only has antineo- 
plastic activity [ 1 1,12] but is also a member of a new class 
of membrane-active anti-HIV agents [13]. Yet, the closely 
related ether lipid analog (R)-Lyso-PAF, in which the 
-OMe group of (R)-ET-18-OMe or the acetyl group of 
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(R)-PAF has been replaced by -OH (Fig. 1), has no similar 
biological activities. Understanding of the structure-func- 
tion relationships of these substances [3,4] can be increased 
by a detailed study of the specific interaction principles, 
packing properties and thermal behavior of these molecules. 
This work is focused on membranes composed of each 
ether lipid alone, with no model membranes present. Study 
of these simple systems permits insight into the interac- 
tions of these molecules with one another and with water 
that crystal structures and studies of these molecules in 
model membranes cannot provide. Our experiments how 
that all three compounds can form bilayers. 
Huang et al. have conducted extensive mpirical studies 
of interdigitated gel phases in fully hydrated phosphatidyl- 
cholines. They have predicted the existence of these phases 
from the difference in length of the two hydrocarbon 
chains, even predicting the temperature of the phase transi- 
tion [14,15]. Although their studies were conducted using 
acyl rather than ether lipids, a broad application of their 
work predicts the existence of an interdigitated lamellar 
gel phase for these three compounds. The present work 
confirms the existence of this phase and provides detailed 
information on its structure for these three compounds. In 
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Fig. 1. Chemical structures of the ether lipid analogs. 
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small-angle X-ray diffraction experiments hese molecules 
gave electron density profiles typical of interdigitated bi- 
layers, with d-spacings of about 42 to 50 A in the gel 
phase at 98% relative humidity (RH). The DSC data 
confirm these results and show that the gel-liquid crys- 
talline phase transitions of these molecules at 98% RH 
occur at 25-30°C. 
2. Materials and methods 
2.1. Synthesis 
(R)-PAF, (R)-ET-18-OMe and (R)-l-O-octadecyl-sn- 
glycero-3-phosphocholine [(R)-Lyso-PAF] (Fig. 1) were 
synthesized in our laboratories using modifications of pub- 
lished synthetic methods [12,16,17]. 2,3-O-Isopropylidene- 
1-O-octadecyl-sn-glycerol was prepared by the method of 
Hirth and Bamer [16]. Alternatively, 2,3-O-isopropylidene- 
sn-glycerol was refluxed with KOH and 1-bromooctade- 
cane in toluene [2]. The isopropylidene moiety was re- 
placed by the benzylidene group by refluxing with benzyl- 
aldehyde in the presence of catalytic p-toluenesulfonic 
acid for 5 h [18]. The resulting 2,3-O-benzylidene-l-O-oc- 
tadecyl-sn-glycerol was a 45:55 (cis to trans) mixture of 
epimers at the benzylidene carbon. Reductive opening of 
the benzylidene was carried out by using a solution of 
LiA1H 4 and A1C13 in Et20, giving a 4:1 mixture of 
3-O-benzyl- 1-O-octadecyl-sn-glycerol and 2-O-benzyl- 
O-octadecyl-sn-glycerol. The minor product was then 
treated with [3-bromoethyldichlorophosphate [19-21]. 
Trimethylamine was used to give (R)-2-O-benzyl-l-O-oc- 
tadecyl-sn-glycero-3-phosphocholine. This was debenzy- 
lated by hydrogenolysis using palladium hydroxide as a 
catalyst to give 1-O-octadecyl-sn-glycero-3-phosphocho- 
line [(R)-Lyso-PAF]. This was acetylated using acetic 
anhydride in CHC13 to give 2-O-acetyl-l-O-octadecyl-sn- 
glycero-3-phosphocholine [(R)-PAF] [22]. 
(R)-2-O-methyl-l-O-octadecylglycero-3-phosphocho- 
line [(R)-ET-18-OMe] was synthesized by the method 
reported for the preparation of 1-O-alkyl-2-O-alkyl'-sn- 
glycerols [12,23] starting with 2,3-O-isopropylidene-sn- 
glycerol via 13-bromoethyl phosphodiesters [19-21]. 
The optical purities of the sn-glycero-3-phosphocholine 
ether lipids as percent enantiomeric excess (% ee) were 
determined unambiguously b  ~H-NMR after converting a 
synthetic precursor to its (R)-3,3,3-trifluoro-2-methoxy-2- 
phenylpropionate (Mosher's ester) [24]. The optical purity 
of the 1-O-alkyl-3-benzyl-sn-glycerol (prepared from 2,3- 
O-isopropylidene-sn-glycerol) wasfound to be 99.0 + 0.5 % 
ee from the integration of the benzyl protons in the I H- 
NMR spectra of the corresponding Mosher's ester [23]. 
The (R)-isomer of each compound was used exclusively in 
all of our experiments. 
2.2. Small-angle X-ray diffraction 
Partially hydrated ( = 98% RH) vesicle dispersions were 
prepared by first drying 1 mg of the compounds in test 
tubes under vacuum for 12 h to remove residual organic 
solvents. Then --~ 1 ml distilled water was added while the 
samples were being vortexed. The resulting suspensions 
were sonicated in a bath sonicator for 15 min until the 
suspension became translucent. After sonication, = 15 ~1 
of the vesicle suspension was pipetted onto aluminum foil 
and dried at < 35°C. The pipetting and drying were 
repeated twice more; then the samples were mounted on a 
curved glass support. The samples were partially rehy- 
drated for 24 h in closed vials over a saturated solution of 
sodium sulfate to maintain = 98% RH, then sealed in 
brass diffraction canisters containing potassium sulfate so- 
lution. Occasionally, especially for the purpose of phase 
determination, data were collected at partial hydration 
states other than that resulting from 98% RH. 98% RH 
provides a high hydration state, but not full hydration. The 
result of partial hydration is better sample order and thus 
better X-ray diffraction, while reasonable physiological 
relevance is maintained. 
Diffraction data were collected using an Elliot GX18 
rotating anode microfocus generator (Marconi Avionics) 
supplying Cu K~ radiation (X = 1.54 ,~) in conjunction 
with a fixed-geometry beamline consisting of a single 
Franks mirror providing line focus at the detection plane, 
vertical and horizontal imiting slits, a nickel filter, the 
curved specimen, a tungsten beamstop, and electronic de- 
tection. The beam height at the specimen was = 1 mm. 
Small angle X-ray diffraction patterns were collected using 
a Braun one-dimensional position-sensitive proportional 
counting gas flow detector (Innovative Technology, South 
Hamilton, MA). The specimen-to-detector distance was 
130 mm. Most data were collected at 14°C; some were 
collected at higher temperatures. Data were transferred 
directly to a VAX computer system for reduction and 
analysis. Phases were determined by a swelling series 
[25,26]. It was assumed that the electron density profiles 
should be consistent with a bilayer structure. Repetitions of 
the diffraction experiments for each compound at 98% RH 
gave electron density profiles consistent with those from 
the original experiments. 
2.3. Differential scanning calorimetry. 
DSC experiments at98% RH were carried out to inves- 
tigate the mesomorphic properties of the preparations and 
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to help interpret he diffraction data. Partially hydrated 
vesicle samples were made using the same method as for 
the X-ray samples, but with 5 mg of compound. The 
vesicle samples were deposited on a glass surface, dried, 
and scraped into stainless teel DSC pans (Perkin Elmer, 
0.25 cm height X 0.5 cm diameter). The sample pans were 
suspended in closed vials at 98% RH for 48 h, then sealed. 
After the pans were sealed, several cycles of heating the 
sample above its transition temperature and then cooling 
were carried out to assure proper mixing. Sometimes the 
samples were cycled through the phase transition at 98% 
RH several times both before and after sealing the pans, to 
assure that the hydration state was as homogeneous as 
possible at 98% RH. This process did not alter the shape of 
the transition. The DSC experiments were conducted in a 
Perkiu Elmer DSC-7 instrument at a scan rate of 2.5 
K/rain over a suitable temperature range for each com- 
pound. 
2.4. Computer graphic representation 
Molecular modeling and graphic display were per- 
formed on a 4D/70GT IRIS Silicon Graphics workstation 
using the Biosym InsightII(2.2.0)/Discover(2.9.0) molecu- 
lar modeling package (Biosym, San Diego, CA). The 
structures of the individual alkyl lysophospholipid 
molecules were built from the X-ray crystallographic model 
of (R)-ET-18-OMe [27] and were energy-minimized using 
the Biosym program. The minimum energy conformation 
of (R)-ET-18-OMe was then used as a starting template on 
which the structures of (R)-PAF and (R)-Lyso-PAF were 
generated by deletion and/or addition of atoms at standard 
bond lengths and bond angles under the Biosym software. 
The energy-minimized molecules were used to build bi- 
layer structures consistent with the experimental e ectron 
density profiles. 
3. Resu l ts  
3.1. Small angle X-ray diffraction 
Fig. 2 shows a typical set of diffraction data from 
(R)-ET-18-OMe. The quality of the data from the other 
ether lipids was similar. Swelling experiments were con- 
ducted to determine the phases [25,26]. The phases were 
deduced by observation of the behavior of the transform 
close to the nodes and by use of the minimum wavelength 
principle [28]. Fig. 3 shows the structure factors for (R)- 
PAF, (R)-ET-18-OMe and (R)-Lyso-PAF. The bilayers 
showed only small structural changes, which were inter- 
preted as the effect of increased isorder of the ether lipid 
molecules at higher water contents. 
The reflections between 0.00 A t and 0.10 A-] were 
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Fig. 2. A diffraction pattern from (R)-ET-18-OMe at 98% RH and 14°C, before Lorentz and background correction. The inset shows the fourth and fifth 
orders, scaled up. Diffraction quality from (R)-PAF and (R)-Lyso-PAF was similar. 
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Fig. 3. Structure factors [diffraction amplitude vs. h /d  (~- i ) ]  of the 
three ether lipid analogs. Samples were equilibrated at 98% RH (A), 
87% RH (m), 66% RH (O), and 13% RH ( I )  at 14°C. 
easily assigned phases, but because of the extended zero in 
o I 
the data at about 0.12 A- , the phases in that region were 
ambiguous. These reflections could be given phases of 
either 0 or v without violating the minimum wavelength 
principle. Therefore, we assumed that the electron density 
profiles should be consistent with a bilayer structure. All 
phase combinations were systematically tested for each set 
of data, and only one combination in each case gave a 
profile that was consistent with a bilayer structure. The 
structure factors for the three molecules fell on similar 
smooth curves, which provided evidence that all of the 
ether lipids had the same phases (-tr,'rr,0,~,0) for the 
structure factors corresponding to the 1st, 2nd, 3rd, 4th, 
and 5th orders. 
Using the correct phase combination, we calculated 
electron density profiles (Fig. 4) for (R)-PAF, (R)-ET-18- 
OMe and (R)-Lyso PAF at 98% RH and 14°C (in the gel 
phase). In each profile the two peaks representing the lipid 
headgroups were centered at approximately + 17 A. The 
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Fig. 4. Electron density profiles of the three ether lipid analogs at 98% 
RH and 14°C, showing the typical pattern of interdigitated bilayers. A, 
(R)-PAF, d= 43.30 ,~; B, (R)-ET-18-OMe, d= 42.93 A; C, (R)-Lyso- 
PAF, d = 50.96 ,~. The profiles have been normalized to I because there 
is no absolute lectron density scale; the electron density is in arbitrary 
units. Superimposition f the electron density profiles shows differences 
at the center interdigitated regions of the terminal alkyl chains and in the 
water regions (see text). The inset shows an electron density profile of 
DMPC at 12°C (in the gel state, not interdigitated) for comparison. 
intermediate-density regions at the edges of the profile, 
outside the headgroup eaks, represent the water spaces 
between the bilayers. The central ow-density region be- 
tween the headgroup peaks, which represents he hydrocar- 
bon core, contained two lowest-density regions separated 
by about 10 ,~. In contrast, a typical dimyristoylphospha- 
tidylcholine (DMPC) electron density profile has a single 
central trough in this region, representing the methyl groups 
(inset, Fig. 4). The presence of the small peak in the center 
of the profile suggests that in these ether lipids, hydrocar- 
bon chains from opposing monolayers have interpene- 
trated. 
The electron density profiles in Fig. 4 were normalized 
so that the headgroups and lowest density regions of all of 
the profiles fall at 1.0 and 0.0 on the scale, respectively. 
The absence of an absolute lectron density scale prohibits 
direct comparison of electron densities among the three 
structures, but electron densities within each individual 
profile can be compared, as well as the overall shapes of 
the profiles. The major differences in the profiles for the 
three occur in the central ow-density region between the 
headgroup eaks, that is, in the hydrocarbon core of the 
bilayer. Related differences occur in the water space. 
(R)-Lyso-PAF has the lowest electron density at the cen- 
tral region (compared to the density of its own headgroup 
region, not to the central regions of the other two struc- 
tures or to their headgroup regions), and the highest elec- 
tron density at the water space between the headgroups 
from two adjacent bilayers. (R)-ET-I 8-OMe has the high- 
est relative electron density at the bilayer center and the 
lowest in the water space. (R)-PAF has intermediate r la- 
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Fig. 5. DSC scans howing the main transition of (R)-PAF (A), (R)-ET- 
18-OMe (B), and (R)-Lyso-PAF (C), rehydrated at 98% RH to be 
analogous tothe X-ray samples. The heating rate was 2.5 K/rain. The 
scans were normalized toenthalpy per gram because ofslightly different 
masses of the ether lipids in the samples. 
tive values in both regions. This suggests a relationship 
between the degree of interdigitation of the chains and the 
amount of water incorporated between the bilayers. The 
electron density between bilayers for (R)-ET-18-OMe is 
less than that at the bilayer center. Its headgroup eak is 
relatively narrow, and its interdigitated region is relatively 
wide. These characteristics indicate that its lipid packing is 
probably the most efficient of the three. The broad head- 
group peak of (R)-Lyso-PAF suggests that its -OH group 
may attract more water through H-bonding than the sn-2 
substituents of (R)-ET-I8-OMe or (R)-PAF do, causing 
less efficient lipid packing and spreading out the head- 
group electron density. 
3.2. Differential scanning calorimetry 
Fig. 5 shows the main phase transitions of (R)-PAF, 
(R)-ET- 18-OMe, and (R)-Lyso-PAF at 98% RH. All three 
Table I 
Transition properties of the ether lipid analogs at 98% RH 
Molecule Phase Phase FWHM ~ Enthalpy 
transition transition AT1~ z (K) change AH 
onset (°C) peak (T~) (kcal/mol) 
(°C) 
(R)-PAF 23.61 29.02 6.38 7.812 
( R)-ET- 18-OMe 23.70 28.50 6.00 7.910 
(R)-Lyso-PAF 24.44 32.47 8.75 7.309 
Full width at half maximum. 
molecules gave broad phase transition peaks with a shoul- 
der at the low-temperature side. The shoulder indicates 
either that two populations are involved in the transition, 
or that two transitions are taking place. Two populations 
might correspond to two hydration states due to inhomoge- 
neous hydration at 98% RH. Accordingly, some samples 
were annealed by cycling several times through the phase 
transition at 98% RH before the pans were sealed, as well 
as after sealing, to ensure that hydration was homoge- 
neous. This procedure did not change the shape of the 
endotherms. (R)-Lyso-PAF gave the broadest peak (ATI/2 
= 8.75 K) and the highest phase transition temperature 
(T c = 32.47°C) (see Table 1). (The melting transition tem- 
perature given here is the temperature atthe peak; both the 
peak and the onset temperatures of the transition are given 
in Table 1.) (R)-ET-18-OMe showed the lowest phase 
transition temperature and smallest full width at half maxi- 
mum of the phase transition. However, (R)-Lyso-PAF 
gave the smallest enthalpy change (A H = 7.039 kcal/mol) 
and (R)-PAF the largest (AH= 7.912 kcal/mol). The 
DSC results confirm that the compounds were in the gel 
phase at 14°C, the temperature at which the X-ray diffrac- 
tion experiments were conducted, and are consistent with 
the observed changes in d-spacing with temperature (Fig. 
55 
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Fig. 6. Temperature dependence of d-spacing at 98% RH. Circles and solid line, (R)-PAF; triangles and dotted line, (R)-ET-18-OMe; squares and dashed 
line, (R)-Lyso-PAF. Each line shows the change in d-spacing of a single sample as it was heated, indicating the similar esponses of the three compounds 
to warming. In each case the d-spacing decreased rapidly after the onset of the phase transition. (R)-Lyso-PAF shows the largest change in d-spacing. 
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6); that is, as the temperature ises, the d-spacing begins to 
decrease rapidly only after the phase transition has begun. 
4. Discussion 
The diffraction patterns and electron density profiles 
(Fig. 4) from (R)-PAF, (R)-ET-18-OMe and (R)-Lyso- 
PAF at 98% RH strongly indicate that the hydrocarbon 
chains of these ether lipids are interdigitated. The profiles 
in Fig. 4 are similar to those derived by Ranck et al. [29] 
for the interdigitated phase of dipalmitoylphosphatidyl- 
glycerol (DPPG) in the gel state. The electron density 
profiles show that the distances between headgroup eaks 
are 32.1, 30.6 and 35.6 ,~ for (R)-PAF, (R)-ET-18-OMe 
and (R)-Lyso-PAF, respectively, in contrast to the 43.8 
expected for two fully extended DPPC chains that are not 
interdigitated in the gel phase at the same temperature. 
Moreover, the electron density profiles in Fig. 4 do not 
have the deep terminal methyl trough in the center of the 
profile that is observed when the hydrocarbon chains are 
not interdigitated and the methyl groups are localized in 
the bilayer center, as in noninterdigitated DPPC bilayers. 
Taking into account hat the acyl chains of DPPC are 16 
carbons long and those of the ether lipids are 18 carbons 
o 
long, and assuming 1.25 A/CH2, the differences between 
the calculated bilayer width for fully extended non-inter- 
digitating chains (48.8 ,~) and the actual ether lipid bilayer 
widths for the interdigitating chains are 16.7 A (13 CH2), 
18.2 A (15 CH 2) and 13.2 ~, (11 CH2), for (R)-PAF, 
(R)-ET-18-OMe, and (R)-Lyso-PAF, respectively. Ac- 
cording to this calculation, the hydrocarbon chains of these 
molecules have penetrated up to the 13th to l lth CH 2 
group of the ether lipids of the opposing monolayer. 
However, these calculated ifferences are larger than the 
lengths of the interdigitated regions observed in the elec- 
tron density profiles [(R)-PAF: 9.3 ,~ (7 CH2), (R)-ET- 
18-OMe: 12.3 A (10 CH 2) and (R)-Lyso-PAF: 6.8 A (5 
CH2)]. Our explanation is that the chains may possibly be 
tilted in these interdigitated bilayers in the gel phase. 
Computer graphical representations of bilayer structures 
that might explain the X-ray diffraction results were con- 
structed. When the headgroup separation of (R)-ET-18- 
OMe was set at 41.5 A, making the interdigitated portion 
of the chain 15.2 A long, a tilt angle of 35 ° with respect to 
the bilayer normal yielded a headgroup-headgroup separa- 
tion of 30.6 .A. The projection of the interdigitated portion 
of the chain on the bilayer normal was 11.9 A, which is 
close to the experimental value (12.3 A). A similar process 
applied to (R)-Lyso-PAF achieved vertical projections on 
the bilayer normal of 35.8 ,~ for the headgroup-headgroup 
distance and 7.7 ,~ for the interdigitated region. Other 
combinations of degree of interdigitation and tilt angle 
may also be consistent with the X-ray data. 
These packing models of the ether lipid bilayers indi- 
cated that there may be some space (5-l0 A) between the 
terminal methyl groups of the chains and the glycerol 
backbone region of the opposing monolayer with which 
the chains are interdigitating. That space should allow the 
alkyl chains to penetrate farther into the opposite mono- 
layer than the models indicate - the chains should interdig- 
itate until the terminal methyl of the chains reaches the 
carbonyl of (R)-PAF, or ether oxygen of the (R)-ET-18- 
OMe, or -OH group of (R)-Lyso-PAF. However, the 
experimental data indicate that partial interdigitation f the 
alkyl chains is more likely than full interdigitation. The 
crystal structure of (R)-ET-18-OMe may provide an expla- 
nation of the difference [27]. In the crystal structure, 
further interdigitation is prevented by a molecule of water 
of hydration at the headgroup that is positioned in the path 
of the intruding hydrocarbon chains. The degree of water 
penetration i to the bilayer depends on the composition of 
the lipid [30]. The substituent group at the 2-position of the 
glycerol backbone, especially the -OH group of (R)-Lyso- 
PAF, may hydrogen bond with water to expand the inter- 
face region and/or make it more polar. This expansion 
may prevent he chains from penetrating further, resulting 
in partial instead of full interdigitation. The observation 
that (R)-Lyso-PAF has the widest headgroup region also 
supports this explanation. The width of the headgroup 
region may also be modified by possible interactions be- 
tween the charged regions of the headgroup and the sub- 
stituent at the sn-2 position. Such interactions might affect 
headgroup orientation, and coupled with the high degree of 
hydration might alter the surface charge characteristics and 
the dielectric onstant of the headgroup region relative to 
those of the other two ether lipids. 
The DSC results are summarized in the Table. The 
calorimetric behavior of (R)-Lyso-PAF (broadest ATI/2, 
highest T c and smallest A H) upon interdigitation can be 
rationalized as follows. The phase transition temperature is 
markedly dependent on the chain length and the chemical 
structure of the lipid hydrocarbon chains, as well as on the 
nature of the polar headgroup interactions [31,32]. All 
three molecules have the same sn-1 chains and the same 
phosphocholine headgroup. The only differences among 
the three occur at the glycerol backbone at the sn-2 chain, 
in the interface region. Therefore, the changes in ATI/2,  T~ 
and A H are determined by the identity of the substituent 
group at the 2-position of glycerol backbone. At neutral 
pH all three molecules are zwitterions, but (R)-Lyso-PAF 
melts about 4 K higher than others. This reflects the ability 
of (R)-Lyso-PAF to interact with an adjacent (R)-Lyso- 
PAF molecule via hydrogen bonding, achieving higher 
stability. Because of its H-bonding, one might surmise that 
(R)-Lyso-PAF would have highest A H of the three, also. 
Actually, it has the smallest A H, which might be ex- 
plained as follows. The X-ray data indicated different 
degrees of interdigitation i  bilayers of the three molecules 
because of the structural differences at the 2-position of 
glycerol backbone. (R)-ET-18-OMe and (R)-PAF are in- 
terdigitated farther than (R)-Lyso-PAF. The interdigitated 
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parts of the alkyl chains would restrict one another and 
adopt an almost all-trans conformation to achieve mini- 
mum energy in the gel phase. (R)-Lyso-PAF has less 
extensively interdigitated alkyl chains, so the non-interdig- 
itated part of the alkyl chain may adopt more gauche 
conformations, causing (R)-Lyso-PAF to have higher en- 
ergy in the gel phase. Fourier transform infrared spec- 
troscopy (FTIR) could be used to test this hypothesis. 
However, FTIR has shown that in DPPC in the liquid 
crystalline state, there are only about 3.6-4.2 gauche 
conformations per chain [33,34]. For these saturated ether 
lipids in the gel state, even fewer gauche conformations 
might be expected. 
(R)-Lyso-PAF would also need less energy (AH)  to 
overcome the energy barrier for melting. (R)-PAF and 
(R)-ET-18-OMe have lower energy in the gel phase and 
need more energy to pass the barrier, so their enthalpy 
changes (AH)  are larger than that of (R)-Lyso-PAF. We 
have assumed that the contribution of H-bonding to A H is 
smaller than that of interdigitation. The wide melting 
temperature range and broad endotherm (largest ATe/2) of 
(R)-Lyso-PAF indicate that its cooperativity is poor; the 
packing properties indicated by the diffraction data are 
consistent with this idea. 
The phase behavior of 1-O-octadecyl-2-O-methyl-rac- 
glycero-3-phosphocholine has been investigated in the 
temperature range -10  to 40°C by Maurer et al., using 
dispersions of micelles prepared at 40°C [35]. (Our vesicle 
samples probably also contain some micelles in addition to 
multilamellar vesicles.) Lipid dispersions exhibited en- 
dotherms at 2.5, 17, and 20°C on heating, but only one 
transition, from a micellar to a lamellar gel phase at 6°C, 
during recooling. Below 6°C X-ray diffraction indicated a 
lamellar phase (d = 51 ,~) with tilted and/or  interdigitated 
chains. Huang et al. have used Raman and 31p-NMR 
spectroscopy to study the phase transitions of PAF in 
aqueous dispersions [36]. Two transitions were observed, 
at 9.2°C (large vesicles of interdigitated lamellar gel to 
smaller vesicles of more disordered interdigitated lamellar 
gel) and 18.4°C (interdigitated lamellar gel to micellar 
phase). Our X-ray diffraction results also indicate an inter- 
digitated lamellar phase for these compounds at 98% RH. 
Our DSC results show different transition temperatures, 
because of the lower hydration state and oriented multi- 
layer form of our samples. 
5. Conclusions 
The amphipathic ether lipids discussed here appear to 
form bilayers similar to lipid bilayers, with interdigitated 
and probably tilted chains. The results indicate that these 
molecules might easily insert themselves into membrane 
bilayers and align themselves in the bilayer like natural 
lipids. Biological membranes are a site of drug action. 
Drugs must get into or pass through membranous barriers 
to reach their receptors (if they exist), or perturb mem- 
branes and modify the properties of the bilayer or those of 
the membrane-associated functional proteins. Perturbation 
of the membrane may be related to the recently reported 
anti-HIV activity of (R)-ET-18-OMe. The very low bio- 
logical activity of (R)-Lyso-PAF may be due to its higher 
capacity for hydration and hydrogen bonding. 
The ether lipids represent a new class of biologically 
active agents whose pharmacology is not yet understood 
and which are attracting considerable attention. Presently, 
we are carrying out high-resolution 2D-NMR experiments 
combined with computer simulation to study the conforma- 
tion of these molecules. 
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